Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine April 2007, 48 (4) 9a-10a;
  • Article
  • Info & Metrics
  • PDF
Loading

Patient-friendly dose calculation: Sgouros reviews the recent history of and challenges to clinical dosimetry in targeted radionuclide therapy and previews an article in this issue of JNM that offers a novel approach for cell-level dosimetry.
Page 496

Beyond SPECT in SSR imaging: Schillaci outlines the current status of somatostatin receptor scintigraphy, CT, and PET imaging of neuroendocrine tumors and previews an article in this issue of JNM that describes a promising PET tracer.
Page 498

18F-FDG in MTC: Ong and colleagues assess the effect of postthyroidectomy calcitonin levels on the ability of 18F-FDG PET and PET/CT to detect residual, recurrent, or metastatic medullary thyroid carcinoma.
Page 501

Figure

Novel PET tracer for NETs: Gabriel and colleagues evaluate the diagnostic efficacy of a new gadolinium-labeled somatostatin analog for PET imaging in patients with known or suspected neuroendocrine tumors and compare clinical results with those from scintigraphy and CT.
Page 508

Figure

PET and MRI in glioma management: Floeth and colleagues identify 18F-FET PET and MRI characteristics that are validated as strong predictors of clinical course and outcome in adult patients with newly diagnosed, nonenhancing, supratentorial low-grade glioma.
Page 519

Prone PET/MRI fusion in breast cancer: Moy and colleagues describe a prototype positioning device that allows the acquisition of prone PET studies to facilitate fusion of 18F-FDG PET and MRI scans for enhanced detection of breast cancer.
Page 528

Figure

Dedicated, high-resolution neuroimaging: Leroy and colleagues evaluate the clinical utility of high-resolution research tomography for measurement of dopamine transporter binding and compare the spatial resolutions achieved with those of conventional PET scanners.
Page 538

Figure

Simplifying PET amyloid imaging: Ng and colleagues explore the potential of 11C-PIB PET for the diagnosis of Alzheimer's disease and compare visual analysis of PIB images with visual readings of 18F-FDG images.
Page 547

Figure

Imaging dense amyloid plaques: Kudo and colleagues report on a novel compound for in vivo PET detection of dense amyloid deposits and describe initial findings in healthy individuals and patients with Alzheimer's disease.
Page 553

Detecting apoptosis in heart failure: Kietselaer and colleagues evaluate the utility of annexin A5 imaging for noninvasive assessment of programmed cell death in patients with advanced nonischemic cardiomyopathy and in nonsymptomatic genetic relatives.
Page 562

Standardized 4-hour gastric emptying: Ziessman and colleagues review their experience with a standardized protocol for gastric-emptying studies and investigate the added value of 4-h imaging as well as the ability of the lag phase to predict delayed emptying.
Page 568

PET and neuronal stress: Boutin and colleagues investigate a new peripheral benzodiazepine receptor ligand suitable for PET monitoring of neuroinflammatory processes as an indirect indicator of neurodegeneration.
Page 573

Figure

Antigen targeting and plaques: von Lukowicz and colleagues test the ability of the human antibody G11, specific to the C domain of tenascin-C, to detect murine atherosclerotic plaques ex vivo and discuss the implications of their findings for molecular imaging.
Page 582

Dual membrane–protein reporter system: Hwang and colleagues describe a combination of human sodium iodide symporter and mutant dopamine D2 receptor transgenes to create a noninvasive positron and γ-imaging reporter system capable of noninvasive monitoring of cellular status.
Page 588

Limiting PRRT nephrotoxicity: Gotthardt and colleagues evaluate the ability of several agents to inhibit renal accumulation of different radiopeptides in an effort to enhance the efficacy of peptide receptor radiotherapy.
Page 596

microPET study reliability: Dandekar and colleagues determine the reproducibility of serial 18F-FDG small-animal PET imaging in mouse xenograft models to assess the efficacy of this approach in measuring tumor response to therapy.
Page 602

Optimal angiogenesis monitoring: Wyss and colleagues measure uptake of three 18F-labeled PET tracers in gliomas in a rat model and correlate their findings with the uptake of a radiolabeled anti–extra domain B antibody as a marker of neoangiogenesis.
Page 608

Figure

Radiolabeled gastrin analogs: Mather and colleagues report on a study designed to identify a radiolabeled peptide with improved tumor-to-kidney pharmacodynamics for peptide receptor radionuclide imaging and therapy.
Page 615

Figure

Intraoperative γ-camera in breast cancer: Mathelin and colleagues report on the ability of a prototype mini γ-camera to precisely localize and determine the depth of sentinel lymph nodes in a series of patients with infiltrative breast cancer.
Page 623

Figure

Respiratory gating in SPECT: Gil and colleagues describe a technique for correcting the respiration effect in myocardial perfusion imaging and assess its efficacy in clinical studies.
Page 630

Correcting 3D 201Tl SPECT: Xiao and colleagues report on a Monte Carlo–based scatter correction approach that is suitable for 201Tl cardiac imaging and also describe benefits noted in several image-quality metrics.
Page 637

Dosimetry and target cell distribution: Watchman and colleagues describe direct measurement of hematopoietic and progenitor cells as well as marrow vasculature structures within images of human disease-free bone marrow.
Page 645

Figure

Assessing gene therapy: Nimmagadda and colleagues investigate the biodistribution, metabolism, and DNA uptake of 18F-FIAU in a canine model and report on the potential of this tracer as a reporter probe to monitor HSV-tk gene expression and bacterial infections.
Page 655

All about SPECT: Madsen presents an educational overview of basic physics and recent innovations in SPECT imaging and instrumentation, including the advantages leveraged by new preclinical small-animal systems capable of providing information unavailable from other modalities.
Page 661

ON THE COVER

A novel PET compound has displayed preferential binding to dense amyloid deposits in the brains of patients with Alzheimer's disease. The tracer is retained in the cerebral cortices of the patients but not of aged healthy individuals and is distributed primarily in the posterior association area of the brain, corresponding well with the preferred site for neuritic plaque deposition. This compound is a promising PET probe for the in vivo detection of dense amyloid deposits in Alzheimer's disease patients.

Figure

SEE PAGE 560

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 48 (4)
Journal of Nuclear Medicine
Vol. 48, Issue 4
April 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Apr 2007, 48 (4) 9a-10a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Apr 2007, 48 (4) 9a-10a;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Toward Patient-Friendly Cell-Level Dosimetry
  • Somatostatin Receptor Imaging in Patients with Neuroendocrine Tumors: Not Only SPECT?
  • Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels
  • 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
  • Prognostic Value of O-(2-18F-Fluoroethyl)-l-Tyrosine PET and MRI in Low-Grade Glioma
  • Improving Specificity of Breast MRI Using Prone PET and Fused MRI and PET 3D Volume Datasets
  • Assessment of 11C-PE2I Binding to the Neuronal Dopamine Transporter in Humans with the High-Spatial-Resolution PET Scanner HRRT
  • Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease
  • 2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients
  • Noninvasive Detection of Programmed Cell Loss with 99mTc-Labeled Annexin A5 in Heart Failure
  • Experience with a Simplified, Standardized 4-Hour Gastric-Emptying Protocol
  • 11C-DPA-713: A Novel Peripheral Benzodiazepine Receptor PET Ligand for In Vivo Imaging of Neuroinflammation
  • Human Antibody Against C Domain of Tenascin-C Visualizes Murine Atherosclerotic Plaques Ex Vivo
  • Development of a Dual Membrane Protein Reporter System Using Sodium Iodide Symporter and Mutant Dopamine D2 Receptor Transgenes
  • Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides
  • Reproducibility of 18F-FDG microPET Studies in Mouse Tumor Xenografts
  • Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 Gliomas and Correlation with 131I-SIP(L19), a Marker of Angiogenesis
  • Selection of Radiolabeled Gastrin Analogs for Peptide Receptor–Targeted Radionuclide Therapy
  • Precise Localization of Sentinel Lymph Nodes and Estimation of Their Depth Using a Prototype Intraoperative Mini γ-Camera in Patients with Breast Cancer
  • Correction of Heart Motion Due to Respiration in Clinical Myocardial Perfusion SPECT Scans Using Respiratory Gating
  • Evaluation of 3D Monte Carlo–Based Scatter Correction for 201Tl Cardiac Perfusion SPECT
  • Spatial Distribution of Blood Vessels and CD34+ Hematopoietic Stem and Progenitor Cells Within the Marrow Cavities of Human Cancellous Bone
  • Biodistribution, PET, and Radiation Dosimetry Estimates of HSV-tk Gene Expression Imaging Agent 1-(2′-Deoxy-2′-18F-Fluoro-β-d-Arabinofuranosyl)-5-Iodouracil in Normal Dogs
  • Recent Advances in SPECT Imaging
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire